# Actual Use Trial of Tadalafil 5 mg

> **NCT06805513** · PHASE3 · RECRUITING · sponsor: **Sanofi** · enrollment: 2250 (estimated)

## Conditions studied

- Erectile Dysfunction

## Interventions

- **COMBINATION_PRODUCT:** Tadalafil 5 mg tablets with a digital tool.

## Key facts

- **NCT ID:** NCT06805513
- **Lead sponsor:** Sanofi
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-01-30
- **Primary completion:** 2026-01-31
- **Final completion:** 2026-02-28
- **Target enrollment:** 2250 (ESTIMATED)
- **Last updated:** 2025-02-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06805513

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06805513, "Actual Use Trial of Tadalafil 5 mg". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT06805513. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*